Article Details

Brooklyn ImmunoTherapeutics Executes Letter of Intent to Acquire Novellus Therapeutics

Retrieved on: 2021-06-14 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Brooklyn ImmunoTherapeutics Executes Letter of Intent to Acquire Novellus Therapeutics. View article details on HISWAI: https://www.globenewswire.com/news-release/2021/06/14/2246434/0/en/Brooklyn-ImmunoTherapeutics-Executes-Letter-of-Intent-to-Acquire-Novellus-Therapeutics.html

Excerpt

Novellus Therapeutics develops next-generation mesenchymal stem cell products using licensed patented mRNA cell reprogramming and gene editing ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up